2 Renal Unit, Belfast City Hospital, Belfast, BT9 7AB

Slides:



Advertisements
Similar presentations
Terasaki Festschrift 2014 Clinical Relevance of Pre- and Post-Transplant HLA antibodies, Donor-Specific and Non-Donor-Specific HLA Antibodies Detected.
Advertisements

PRA = 36% (21/58) Anti-A11 and B44.
Complement in Heart Allograft Biopsies E. Rene Rodriguez W. M. Baldwin, III.
Transplant Immunology – A User’s Guide!! Dr Mary Keogan Consultant Clinical Immunologist & Medical Director, NHISSOT Beaumont Hospital.
Objectives Overview of HLA genes and their function
… Rejection Transplantation Biology:. Kidney rejection:
The Deceased Donor Kidney Allocation System
SOLID PHASE IMMUNOASSAYS: INTERPRETING PATTERNS Julie Houp, CHS Johns Hopkins University School of Medicine Division of Immunogenetics and Transplantation.
Transmissibility of B19 by transfusion: evaluation of donor viremia prior to performing a linked donor-recipient study M Busch, representing REDS-II Parvo.
Monitoring HLA-specific antibodies
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.
IMMUNOGENETIC TESTS.
Single HLA Antigen Bead Data Interpretation: Normalized Ratios Peter Stastny Transplantation Immunology Division Departments of Internal Medicine and Pathology.
1 Proposal to Update the HLA Equivalency Tables Histocompatibility Committee Fall 2015.
Successful Multivisceral plus Kidney Transplantation of a highly sensitised paediatric recipient; with Eculizumab salvage for hyperacute renal rejection.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
Reference: Gloor J, Stegall MD
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
Donor Matching of Kidney Transplantation
The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant Apr;9(4):812-9.
Hepatitis B virus infection in renal transplant recipients
Important for Sensitized Patients
Cross-matching as part of Pre transfusion compatibility
Compatibility Testing
Graft Dysfunction after Heart Transplantation
The ALERT Trial.
W Tormey6, CJ Thompson1, D Smith1, A Agha1.
Method Background Result Conclusion
Histocompatibility Committee
Hong Kong Workshop Lecture 3 Antigenicity of HLA-DRDQDP Epitopes
Elvira Maličev Blood Transfusion Centre of Slovenia
Proteinuria in a Renal transplant Recipient
Improved long-term graft function and similar height changes with very low-dose steroid versus late steroid withdrawal in pediatric renal transplantation.
Blood Typing Health Occupations.
Hong Kong Workshop Lecture 8 HLA Epitopes and Acceptable Mismatches for Sensitized Transplant Patients.
Major Histocompatibility Complex
Mechanism and Treatment of Antibody-Mediated Rejection
Preservation of Renal Function: The Key to Long-term Kidney Allograft and Patient Survival.
Anand Yuvaraj International Transplant Fellow
CASE PRESENTATION DR SANJAY MAITRA, DR DENISH SAVALIA,
Single Antigen Beat Assay (Luminex) Allows Detection of Immunised Patients with an Increased Risk for Long Term Graft Survival Prior to Transplantation.
KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients 순천향대학교 서울병원 신장내과 R2 김윤석.
Transplantation Pathology
C. Chalklin, C. Colmont, A. Zaidi, J. Warden-Smith, E. Ablorsu
Kidney allocation to highly sensitized patients
Marcelo Pando UNOS Region 5 Collaborative March, 2017
Blood Part 3.
Major Histocompatibility Complex
Risk factors in deceased-donor transplants Risk factor 1988
Dr VINITA AGRAWAL, SGPGI, LUCKNOW
Interesting Case Conference
Volume 82, Issue 5, Pages (September 2012)
Chimerism New Products
Volume 86, Issue 5, Pages (November 2014)
Hong Kong Workshop Lecture 4 Antigenicity of MICA epitopes
Volume 79, Issue 6, Pages (March 2011)
Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease  Florent Delbos, Walid Barhoumi, Ludovic Cabanne,
QOD: 1. Identify the parts of the blood.
An Observational Study on Thrombotic Microangiopathy in Renal Transplant Recipients - A Tertiary Care Centre Experience. Dr Sarang Vijayan Senior Resident.
Figure 1 Identification of anti-HLA antibodies
Volume 85, Issue 2, Pages (January 2014)
Post-transplant membranous glomerulonephritis as a manifestation of chronic antibody-mediated rejection Hyeon Joo Jeong, Beom Jin Lim, Myoung Soo Kima,
Survival after HLA-Matched Sibling Donor HCT for ALL, Age ≥18 Years,
Prognostic algorithm. Prognostic algorithm. Although the temporal relationship between PLA2R Ab levels and disease activity is well established, a time.
Presentation transcript:

2 Renal Unit, Belfast City Hospital, Belfast, BT9 7AB Correlation of Luminex –Single Antigen Bead Assay and Renal function for post-transplant monitoring Mahendra N Mishra 1, Tanya Shovlin 1, Ashley Meenagh 1, Aisling Courtney 2, Jeanie Martin 1 1 Northern Ireland Histocompatibility and Immunogenetics Lab, Blood Transfusion Service Building, Belfast City Hospital, BT9 7TS. 2 Renal Unit, Belfast City Hospital, Belfast, BT9 7AB Introduction BSHI / BTS guidelines recommend use of sensitive solid phase tests for detection characterization of both pre and post –transplant HLA Donor specific antibodies (DSA) Post-transplant single antigen bead (SAB) assay results relevance depends on risk stratification and is used to monitor immunosuppression Retrospective study: data of 25 non- consecutive renal allograft recipients analysed SAB assay at least twice on pre & post transplant samples HLA typing for recipient and donor by r-SSO /SSP Individual DSA > 1000 was taken as positive Temporal profile ,and MFI of DSA was correlated with creatinine levels Patients and Methods Aim and Objectives Evaluate SAB assay for post –transplant DSA monitoring & correlate with serum creatinine Study hierarchy of DSA leading to allograft dysfunction Locus Mismatched Recipients (antigens) DSA % showing DSA/ antigens A 22 32 11 34.4 B 20 28 10 35.7 C 16 5 22.7 DRB1 21 31 9 29 DRB345 17 26 34.6 DQB1 18 24 14 56 DPB1 4 15.3 Donor – recipient mismatches & DSA with MFI> 1000 Results Table 2: Parameter Value Recipient age Range 2 - 67 years, (Mean = 38) Female recipients 9 (36%) Deceased organ recipients 10 (40%) Retransplants HLA incompatible transplants 4 (16%) Demographic profile of 25 patients Results Table 1: Relationship of DSA with renal function HLA DSA in normal and compromised renal function Chart depicting peak DSA and mean creatinine for seven recipients with normal renal function SAB assay is used for post-transplant monitoring Anti–HLA DQB1 was most frequent and anti-DP least common with anti-HLA C intermediate value probably due to lower expression Recurrence of original disease seen in two cases with no DSA Reactivity against all 7 loci observed in patients with DSA, but normal renal function. Discussion Patients are non consecutive and all DSA is not de-novo Small sample size Post–Transplant DSA is done selectively, often for those with impending graft dysfunction Limitations Elevated DSA may not be concordant with rise in serum creatinine Existing methods were inadequate for discerning between pathogenic & innocuous antibodies Discussion HLA–DQB1 DSA were most common Both DSA levels and renal function have to be considered for treatment monitoring Clinical significance of individual & additive DSA values have to be correlated with allograft function Conclusions respect & dignity openness & trust leading edge learning & development accountability